{
  "paper_metadata": {
    "pmid": "37725003",
    "title": "Genetic screening for hereditary transthyretin amyloidosis with polyneuropathy in western Sicily: Two years of experience in a neurological clinic",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data for affected and unaffected carriers."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.191C>T",
      "protein_notation": "p.Phe64Leu",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 14,
        "demographics": "Age range not specified; includes both male and female patients.",
        "phenotype": "Hereditary transthyretin amyloidosis with polyneuropathy (ATTRv\u2010PN)"
      },
      "penetrance_data": {
        "total_carriers_observed": 33,
        "affected_count": 7,
        "unaffected_count": 26,
        "uncertain_count": null,
        "penetrance_percentage": 21.21,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Sensory-motor polyneuropathy",
          "evidence_sentence": "After clinical and neurophysiological evaluation, seven patients (21%) had evidence of sensory\u2013motor polyneuropathy and were started on treatment."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "Presymptomatic carrier",
          "evidence_sentence": "26 presymptomatic carriers of TTR mutation began regular follow-up."
        }
      ],
      "functional_data": {
        "summary": "The Phe64Leu mutation is associated with hereditary transthyretin amyloidosis.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "Strong evidence based on clinical presentation and family segregation.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Phe64Leu was the most frequent genotype found in the study.",
      "key_quotes": [
        "Five mutations occurred among ATTRv\u2010PN patients, with Phe64Leu being the most frequent genotype.",
        "Interestingly, His90Asn, Val20Ala, and Ser77Phe were reported for the first time in Sicily."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.269A>G",
      "protein_notation": "p.His90Asn",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 14,
        "demographics": "Age range not specified; includes both male and female patients.",
        "phenotype": "Hereditary transthyretin amyloidosis with polyneuropathy (ATTRv\u2010PN)"
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "The pathogenic role of the His90Asn variant was confirmed by the presence of amyloid deposits in a salivary gland biopsy.",
        "assays": []
      },
      "segregation_data": "Not specified.",
      "population_frequency": null,
      "evidence_level": "Moderate evidence based on clinical findings.",
      "source_location": "Discussion, paragraph 4",
      "additional_notes": "His90Asn was confirmed as pathogenic in one patient.",
      "key_quotes": [
        "The pathogenic role of the His90Asn variant in our patient was confirmed by the presence of amyloid deposits in a salivary gland biopsy."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.59G>C",
      "protein_notation": "p.Val20Ala",
      "genomic_position": null,
      "clinical_significance": "VUS",
      "patients": {
        "count": 14,
        "demographics": "Age range not specified; includes both male and female patients.",
        "phenotype": "Hereditary transthyretin amyloidosis with polyneuropathy (ATTRv\u2010PN)"
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "The pathogenic role of the Val20Ala variant is supported by a single report.",
        "assays": []
      },
      "segregation_data": "Not specified.",
      "population_frequency": null,
      "evidence_level": "Low evidence due to limited data.",
      "source_location": "Discussion, paragraph 4",
      "additional_notes": "Val20Ala was reported for the first time in this study.",
      "key_quotes": [
        "For Val20Ala a single report supported a pathogenetic role."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.230C>T",
      "protein_notation": "p.Ser77Phe",
      "genomic_position": null,
      "clinical_significance": "VUS",
      "patients": {
        "count": 14,
        "demographics": "Age range not specified; includes both male and female patients.",
        "phenotype": "Hereditary transthyretin amyloidosis with polyneuropathy (ATTRv\u2010PN)"
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Ser77Phe has been reported as pathogenetic.",
        "assays": []
      },
      "segregation_data": "Not specified.",
      "population_frequency": null,
      "evidence_level": "Moderate evidence based on clinical findings.",
      "source_location": "Discussion, paragraph 4",
      "additional_notes": "Ser77Phe was reported for the first time in this study.",
      "key_quotes": [
        "Among them, Ser77Phe has already been clearly reported as pathogenetic."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Clinical features in screened positive versus negative patients.",
      "variants_extracted": 4
    },
    {
      "table_name": "Table 2",
      "table_caption": "Misdiagnoses in hereditary transthyretin amyloidosis patients.",
      "variants_extracted": 0
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 4,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant variants in the TTR gene were extracted, including penetrance data."
  }
}